Lenalidomide is highly active in recurrent CNS lymphomas: phase I investigation of lenalidomide plus rituximab and outcomes of lenalidomide as maintenance monotherapy - Rubenstein, J L; Formaker, P; Wang, X (Hematol Oncol, 2015)
. Abstract 137